SCHEMBL25979441

SCHEMBL25979441

c1ccc(-c2ccc(N(c3ccccc3)c3ccc4oc5cc(-c6nc(-c7ccccc7)nc7ccccc67)ccc5c4c3)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ATM Q13315 1/20 0.44
CYP1A2 P05177 5/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2D6 P10635 5/20 0.38
CYP2C9 P11712 5/20 0.38
CYP2C19 P33261 5/20 0.38
LMNA P02545 4/20 0.38
TSHR P16473 3/20 0.38
PDE5A O76074 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GLA P06280 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
PDK1 Q15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979439 0.97 MEN1 (0.45) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL25979951 0.94 MEN1 (0.47) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL23610021 0.91 MEN1 (0.44) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL24255936 0.91 MEN1 (0.49) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL25979950 0.91 MEN1 (0.48) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL24801509 0.90 MEN1 (0.45) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL23609830 0.89 MEN1 (0.40) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL25979410 0.89 MAPT (0.37) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL24574979 0.89 ALDH1A1 (0.35) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL25979307 0.89 ALDH1A1 (0.35) MEN1KMT2ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 257/4885KMT2A 758/4885ATM 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.